CYT004-MelQbG10

BIOLOGICAL3 trials

Sponsors

Cytos Biotechnology AG

Conditions

Malignant MelanomaMelanoma

Phase 1

Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

CompletedNCT00306514

Cytos Biotechnology AGMelanoma

Updated: 2007-09-20

Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients

CompletedNCT00306566

Cytos Biotechnology AGMalignant Melanoma

Updated: 2007-09-20

Phase 2

Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

CompletedNCT00306553

Cytos Biotechnology AGMalignant Melanoma

Updated: 2006-09-19